Meclofenoxate Hydrochloride for Injection

This product can promote the redox metabolism of brain cells, increase the utilization of carbohydrates, and have a stimulating effect on patients with central nervous system depression.

The active ingredient of this product is meclofenoxate hydrochloride, and the auxiliary material is mannitol.

Suitable for traumatic coma, alcohol poisoning, neonatal hypoxia, and enuresis in children.

1. Intravenous injection or intravenous drip: Adults: 0.1~0.25g once, 3 times a day, dilute with water for injection or 5% glucose injection to 5~10% solution before use. Children: 60mg~100mg once, 2 times a day, can be injected into the umbilical vein. 2. Intramuscular injection: Adults in coma: 0.25g once, once every 2 hours. Neonatal hypoxia: 60mg once, once every 2 hours.

Occasionally there may be excitement, agitation, insomnia, fatigue, stomach discomfort, headache, which can be recovered after stopping the drug.

It is contraindicated for patients with mental overexcitement, extrapyramidal symptoms, or those who are allergic to this product.

Precautions for children: The safety and effectiveness of the drug for children has not been established. Precautions for pregnancy and lactation: The safety and effectiveness of the drug for pregnant and lactating women has not been established. Precautions for the elderly: The safety and effectiveness of the drug for elderly patients has not been established.

Not yet clear.

Keep away from light and store in a sealed container.

0.2g

24 months.

Hubei Wushi Pharmaceutical Co., Ltd.

• Founded in:

  1997-11-19

• Address:

  No. 137, Biyu Road, Anlu City, Hubei Province

• Tax NO.:

  91420000180960817C

• Registered Funds:

  100 million yuan

• Website:

  Log in to view

• Email:

  Log in to view